Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cancer Metastatic × Gastrointestinal × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 225 Pancreatic Neoplasms 133 Carcinoma, Hepatocellular 98 Stomach Neoplasms 92 Colonic Neoplasms 73 Carcinoma, Non-Small-Cell Lung 71 Breast Neoplasms 68 Esophageal Neoplasms 59 Ovarian Neoplasms 51 Rectal Neoplasms 50 Neoplasm Metastasis 47 Lung Neoplasms 47 Neoplasms 46 Liver Neoplasms 45 Cholangiocarcinoma 42 Gastrointestinal Neoplasms 40 Melanoma 35 Endometrial Neoplasms 34 Biliary Tract Neoplasms 28 Prostatic Neoplasms 27 Adenocarcinoma Of Esophagus 26 Esophageal Squamous Cell Carcinoma 24 Squamous Cell Carcinoma of Head and Neck 23 Uterine Cervical Neoplasms 22 Sarcoma 19 Carcinoma, Renal Cell 18 Head and Neck Neoplasms 17 Triple Negative Breast Neoplasms 16 Urinary Bladder Neoplasms 15 Gallbladder Neoplasms 14

Interventions

folfirinox 1 Oxaliplatin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469556 2026-02-20

PASS-01

University Health Network, Toronto

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡